Medical Devices News

Discover the latest on medical devices with press releases highlighting innovations, trends, and regulatory updates shaping the healthcare industry. Stay informed on key developments in medical device design and explore opportunities in patient care solutions.

Sep 7, 2026 at 8:00 AM

Aptar and Aceso Therapeutics Announce Collaboration to Advance Inhaled Antisense Oligonucleotide Therapy for Cystic Fibrosis

CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--Aptar and Aceso Therapeutics Announce Collaboration to Advance Inhaled Antisense Oligonucleotide Therapy for Cystic Fibrosis...
Sep 5, 2026 at 3:00 AM

Evinova and Lothar Medical Announce Strategic Partnership to Modernise Respiratory Clinical Trials with Unified Trial Solution

BAAR, Switzerland--(BUSINESS WIRE)--Evinova, a global leader in AI-native clinical development technology, today announced a strategic partnership with Lothar Medical to help transform the execution of respiratory clinical trials globally. Through the agreement, Evinova’s Unified Trial Solution will integrate with Lothar Medical’s respiratory devices to support a more connected, data-rich trial experience for sponsors, sites, and patients. Evinova Unified Trial Solution is a globally scaled, GxP...
Sep 4, 2026 at 7:00 AM

Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

HAYWARD, Calif.--(BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel and proprietary Nanosecond Pulsed Field Ablation™ (nano-PFA or nsPFA™) technology, today announced that the Compensation Committee of its Board of Directors has granted equity awards to two new employees as equity inducement awards outside of the Company's 2017 Equity Incentive Plan, but under the terms of the 2017 Inducement Equity Incentive Plan. The equity awards were approved and issued...
Sep 4, 2026 at 6:30 AM

Teleflex Features Innovative Dynetic™-35 Balloon-Expandable Cobalt Chromium Stent System at CIRSE 2026

WAYNE, Pa.--(BUSINESS WIRE)--Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced it will showcase innovative technologies at CIRSE 2026 in Copenhagen, reinforcing its commitment to advancing innovation for healthcare providers. Among the featured technologies will be the Dynetic™-35 Balloon-Expandable Cobalt Chromium Stent System. This technology is supported by the previously presented BIONETIC-TRA study, an investigator-initiated study with a...
Sep 3, 2026 at 5:25 PM

Retractable Technologies, Inc. Supports Senator Blackburn’s ONSHORE Manufacturing Act

LITTLE ELM, Texas--(BUSINESS WIRE)--Retractable Technologies, Inc. (“Retractable”) (NYSE American: RVP) announces its support for Senator Marsha Blackburn’s ONSHORE Manufacturing Act, legislation aimed at strengthening domestic production of critical medical supplies. The legislation would provide tax incentives for U.S. manufacturing, including investments in advanced manufacturing equipment and facility modernization. “The ONSHORE Manufacturing Act is the spark American manufacturers need to...
Sep 3, 2026 at 5:23 PM

AI Visionary Ray Kurzweil Joins Subsense as Product and Vision Advisor

SAN FRANCISCO--(BUSINESS WIRE)--Subsense, an AI-native neurotechnology company developing non-surgical, nanoparticle-based brain-computer interfaces (BCIs), today announced that renowned inventor, futurist and AI pioneer Ray Kurzweil has joined the company as a product and vision advisor. The announcement was made at The Subsense Annual Forum – AI Meets the Brain event, which brought together leaders across AI, neuroscience, BCIs and investing to examine where brain technology is headed and how...
Sep 3, 2026 at 4:30 PM

Mainstay Medical Announces Two-Year Outcomes from RESTORE Clinical Trial of ReActiv8®

DUBLIN--(BUSINESS WIRE)--Mainstay Medical Holdings plc today announced the publication of the two-year assessment results from the RESTORE randomized clinical trial of ReActiv8 for the treatment of intractable chronic low back pain. The data show continued improvements in back pain-related disability, pain and quality of life in the ReActiv8 treatment group, and improvements after one year of ReActiv8 therapy in the crossover group that were indistinguishable from the improvements shown by the...
Sep 3, 2026 at 4:30 PM

bioAffinity Technologies to Participate in the H.C. Wainwright 28th Annual Global Investment Conference

SAN ANTONIO--(BUSINESS WIRE)--BIAF President and CEO Maria Zannes will present a corporate update at the H.C. Wainwright 28th Annual Global Investment Conference Sept. 14-16....
Sep 3, 2026 at 2:15 PM

SinglePass Device Achieves 100% Technical Success and Zero Clinically Significant Bleeding Events in Multicenter Study Published in the Journal of Vascular and Interventional Radiology

LAKE FOREST, Calif.--(BUSINESS WIRE)--SinglePass, Inc., developer of the SinglePass biopsy closure device, today announced the publication of a multicenter (Hoag Health System, Newport Beach and Irvine, California) retrospective clinical data study in the Journal of Vascular and Interventional Radiology (JVIR). Across 120 consecutive patients followed for 30 days, the SinglePass device achieved a 100% technical success rate with zero clinically significant bleeding events.1 Percutaneous biopsy...
Sep 3, 2026 at 12:34 PM

Sequenex Renews ISO 13485:2016 Quality Management System Certification

ATLANTA--(BUSINESS WIRE)--Sequenex renews its ISO 13485:2016 certification for the design and development of software for use in medical devices....
Turn Your News Into Headlines
Submit Your Release

Get Story Ideas Delivered to Your Inbox

Sign Up